Key facts
- Astron Health’s last known valuation is $13.7M (Mar 2025).
- It has raised $960K; the latest was Early Stage VC ($960K) in Mar 2025.
- Notable investors include Ventures Together, Forrest Capital, Opal Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Astron Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Astron Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Astron Health
Developer of an artificial intelligence (AI)-powered clinical decision support platform designed for precision oncology applications. The company's platform integrates genomic, transcriptomic, and proteomic data to analyze tumor biology and identify targeted therapies with potential efficacy for individual patients, enabling oncologists to make data-driven treatment decisions and helping healthcare payers reduce costs associated with ineffective therapies.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 8
- Website
- astron.health/
- Ownership
- Privately Held (backing)
Astron Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Astron Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Astron Health in its N-PORT filings yet. We sweep new filings monthly.